Search research articles
Contact Us
Filters
Showing results (71-80 of 97) with videos related to
Page
of 10
Sort By:
Journal of Personalized Medicine
|
August 27, 2021
Let-7a-5p, miR-100-5p, miR-101-3p, and miR-199a-3p Hyperexpression as Potential Predictive Biomarkers in Early Breast Cancer Patients
Paola Fuso, Mariantonietta Di Salvatore, Concetta Santonocito, et al.
Diagnostics (Basel, Switzerland)
|
June 2, 2021
A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory Study
Valentina D A Corino, Marco Bologna, Giuseppina Calareso, et al.
Scientific Reports
|
July 4, 2020
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases
Michele Basso, Salvatore Corallo, Maria Alessandra Calegari, et al.
Cancer Treatment Reviews
|
January 3, 2015
Triple positive breast cancer: a distinct subtype?
Patrizia Vici, Laura Pizzuti, Clara Natoli, et al.
Head & Neck
|
March 4, 2025
Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real-World Data From 17 Italian Centers
Francesca Caspani, Stefano Cavalieri, Ester Orlandi, et al.
The Oncologist
|
June 8, 2021
Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority Study
Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, et al.
BMC Cancer
|
August 23, 2022
Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study
Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, et al.
Cancers
|
January 22, 2021
CDK4/6 Inhibitor Treatments in Patients with Hormone Receptor Positive, Her2 Negative Advanced Breast Cancer: Potential Molecular Mechanisms, Clinical Implications and Future Perspectives
Michela Roberto, Antonio Astone, Andrea Botticelli, et al.
Scientific Reports
|
January 23, 2023
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study)
Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, et al.
Journal of Personalized Medicine
|
December 23, 2020
Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2- Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient Series
Armando Orlandi, Elena Iattoni, Laura Pizzuti, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 97) with videos related to
Sort By:
Page
of 10
Journal of Personalized Medicine
|
August 27, 2021
Let-7a-5p, miR-100-5p, miR-101-3p, and miR-199a-3p Hyperexpression as Potential Predictive Biomarkers in Early Breast Cancer Patients
Paola Fuso, Mariantonietta Di Salvatore, Concetta Santonocito, et al.
Diagnostics (Basel, Switzerland)
|
June 2, 2021
A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory Study
Valentina D A Corino, Marco Bologna, Giuseppina Calareso, et al.
Scientific Reports
|
July 4, 2020
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases
Michele Basso, Salvatore Corallo, Maria Alessandra Calegari, et al.
Cancer Treatment Reviews
|
January 3, 2015
Triple positive breast cancer: a distinct subtype?
Patrizia Vici, Laura Pizzuti, Clara Natoli, et al.
Head & Neck
|
March 4, 2025
Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real-World Data From 17 Italian Centers
Francesca Caspani, Stefano Cavalieri, Ester Orlandi, et al.
The Oncologist
|
June 8, 2021
Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority Study
Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, et al.
BMC Cancer
|
August 23, 2022
Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study
Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, et al.
Cancers
|
January 22, 2021
CDK4/6 Inhibitor Treatments in Patients with Hormone Receptor Positive, Her2 Negative Advanced Breast Cancer: Potential Molecular Mechanisms, Clinical Implications and Future Perspectives
Michela Roberto, Antonio Astone, Andrea Botticelli, et al.
Scientific Reports
|
January 23, 2023
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study)
Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, et al.
Journal of Personalized Medicine
|
December 23, 2020
Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2- Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient Series
Armando Orlandi, Elena Iattoni, Laura Pizzuti, et al.
Page
of 10